Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Enlil Introduces the Industry's First Evidence-Based Milestone View for Medical Device Companies to Streamline Development Phases and FDA eSTAR Prep

      (PRNewsfoto/Enlil, Inc.)

      News provided by

      Enlil, Inc.

      Feb 03, 2026, 12:52 ET

      Share this article

      SHARE A PRE-MADE POST

      Share this article

      SHARE A PRE-MADE POST

      New capability delivers end-to-end traceability across all product development data, connecting milestones, decisions, and evidence across every phase of the medical device lifecycle.

      CAMPBELL, Calif., Feb. 3, 2026 /PRNewswire/ -- Enlil, Inc., the unified product lifecycle traceability platform for medical device innovators, today announced the launch of Milestone View, a new capability designed to help MedTech teams replace fragile, siloed timelines with traceable, execution-ready development milestones. Milestone View will be previewed at MD&M West 2026, February 3–5, in Anaheim, California, at Enlil's Booth #1090.

      Continue Reading

      In an era of increasing product complexity, FDA scrutiny, and compressed development cycles, medical device teams rely on milestones to guide progress. Yet too often, those milestones are managed in isolation, tracked in spreadsheets, slide decks, or project tools disconnected from the systems where regulated work happens. The result is predictable: misalignment across teams, documentation drift, incorrect revisions, late-stage surprises, and avoidable delays during FDA submission and review.

      Enlil Launches Industry's First Evidence-Based Milestone View to Streamline Med Device Development & FDA eStar Prep

      Post this

      Milestone View addresses this industry-wide problem by directly connecting development milestones to the underlying requirements, design outputs, risk controls, change histories, and regulatory evidence that determine actual readiness.

      When Milestones Drift, Risk Follows

      FDA's eSTAR program was designed to standardize and streamline submissions, but many MedTech companies, particularly high-growth startups and lean teams, continue to struggle with execution. Typical challenges include milestones and documentation falling out of alignment, manual tracking across functions leading to version confusion, and weeks of rework to assemble submission-ready packages.

      These gaps don't stem from scientific shortcomings. They stem from organizational fragmentation, where teams can see milestone dates, but not whether the work behind them is complete, traceable, or defensible.

      "Milestones fail when they're treated as calendar events instead of evidence-based checkpoints," said Chiratana Pot, Senior Director of Product Management at Enlil. "MedTech teams need to know whether a milestone is achieved based on completed, approved work, not just whether a date is approaching. Enlil built Milestone View to replace assumptions with traceability, giving teams a clear, shared understanding of readiness."

      From Timeline Tracking to Traceable Execution
      Milestone View is embedded within Enlil's unified platform, allowing teams to manage milestones directly connected to the regulated data that matters most.

      Key features and benefits include:

      End-to-End Traceability Across the Lifecycle: Links milestones to requirements, design artifacts, risk files, changes, and evidence across all phases, from concept through clearance.

      Real-Time Milestone Readiness: Reveals whether supporting documentation and dependencies are complete, aligned, and inspection-ready.

      Unified System of Record: Ends spreadsheet-driven tracking and version confusion by consolidating all product development data on one platform.

      Structured, FDA-Aligned Workflows: Supports audits and eSTAR preparation with pre-formatted templates and traceable outputs, reducing submission preparation from weeks to days. Show auditors that you have everything under control with released documents, records, and a frozen snapshot of the phase at that time.

      Earlier Risk Detection and Fewer Surprises: Flags gaps and inconsistencies before they surface during audits, submissions, or FDA review.

      Change Impact Analysis Agent (coming Q3 2026): Ability to analyze proposed changes and predict impact across all phases. Identifies which milestones need to be reopened or reverified, saving you significant time and preventing mistakes for regulatory submissions.

      By grounding milestones in traceable data rather than static plans, Milestone View enables teams to move faster without introducing downstream regulatory risk.

      A Strategic Shift for MedTech Leaders

      For product, quality, and executive leaders, Milestone View is more than operational visibility; it enables better decision-making.

      "Medical device development doesn't break down because teams aren't working hard enough," said Nader Fathi, CEO of Enlil. "It breaks down when organizations lack a shared, factual view of progress across functions. Milestone View changes that by unifying strategy, execution, and regulatory readiness in one place so that leaders can make informed decisions earlier from a single pane of truth."

      Preview at MD&M West 2026

      At MD&M West 2026, Enlil will show how Milestone View transforms milestones from static dates into evidence-based checkpoints grounded in traceable product data. Attendees will see how development milestones are dynamically linked to requirements, design outputs, risk files, and regulatory evidence, offering a real-time view of readiness across every phase of development.

      Live demonstrations will highlight how teams can identify gaps earlier, prevent documentation drift, and accelerate eSTAR preparation by working from a single, unified system of record. Visitors will also learn how evidence-based milestones enable tighter cross-functional alignment and reduce late-stage rework, audit risk, and FDA information requests.

      Medical device leaders can experience Milestone View firsthand at MD&M West 2026, February 3–5, in Anaheim, California, at Enlil's Booth #1090.

      About Enlil, Inc.

      Enlil is a cloud-native development traceability platform built for medical device and life sciences organizations. Designed to support regulatory readiness across the product lifecycle, Enlil connects quality, regulatory, R&D, manufacturing, and operations teams around a unified system of record.

      By structuring product data for traceability, auditability, and real-time visibility, Enlil helps MedTech innovators manage complexity, reduce risk, and scale compliance from concept through commercialization.

      Learn more at enlil.com.

      MEDIA CONTACT:
      Sandra Schwartzman, RMR & Associates
      (201) 704 – 8583, [email protected]

      SOURCE Enlil, Inc.

      Modal title

      Also from this source

      Enlil Unveils Governed AI Foundation to Ready Medical Device Makers for AI-Assisted Regulatory Review

      Enlil Unveils Governed AI Foundation to Ready Medical Device Makers for AI-Assisted Regulatory Review

      Enlil, Inc., the AI-powered development traceability platform built for medical device and life sciences organizations, today introduced the...

      Enlil Posts Strongest Quarter Yet, Fueled by New Customer Wins and Deeper Expansion Within Existing Customers

      Enlil Posts Strongest Quarter Yet, Fueled by New Customer Wins and Deeper Expansion Within Existing Customers

      Enlil, Inc., the AI-powered development traceability platform built for medical device and life sciences organizations, today announced the strongest ...

      More Releases From This Source

      Explore

      Computer & Electronics

      Computer & Electronics

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      New Products & Services

      New Products & Services

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.